VIRGINIA RETIREMENT SYSTEMS ET Al Purchases New Holdings in DENTSPLY SIRONA Inc. $XRAY

VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 45,634 shares of the medical instruments supplier’s stock, valued at approximately $725,000.

Several other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. raised its position in DENTSPLY SIRONA by 2.8% during the first quarter. Vanguard Group Inc. now owns 20,740,589 shares of the medical instruments supplier’s stock valued at $309,864,000 after purchasing an additional 557,329 shares in the last quarter. Price T Rowe Associates Inc. MD raised its position in DENTSPLY SIRONA by 11.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 13,961,759 shares of the medical instruments supplier’s stock valued at $208,590,000 after purchasing an additional 1,412,517 shares in the last quarter. Fuller & Thaler Asset Management Inc. raised its position in DENTSPLY SIRONA by 4.7% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 12,077,949 shares of the medical instruments supplier’s stock valued at $180,445,000 after purchasing an additional 538,531 shares in the last quarter. AQR Capital Management LLC raised its position in DENTSPLY SIRONA by 119.4% during the first quarter. AQR Capital Management LLC now owns 6,346,685 shares of the medical instruments supplier’s stock valued at $93,423,000 after purchasing an additional 3,453,662 shares in the last quarter. Finally, Edmond DE Rothschild Holding S.A. raised its position in DENTSPLY SIRONA by 26.4% during the first quarter. Edmond DE Rothschild Holding S.A. now owns 2,913,400 shares of the medical instruments supplier’s stock valued at $43,526,000 after purchasing an additional 609,300 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Stock Performance

Shares of XRAY opened at $13.11 on Friday. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13. The stock has a market capitalization of $2.62 billion, a P/E ratio of -2.77, a price-to-earnings-growth ratio of 0.83 and a beta of 0.96. The firm’s fifty day simple moving average is $13.35 and its two-hundred day simple moving average is $14.50. DENTSPLY SIRONA Inc. has a 12 month low of $11.69 and a 12 month high of $24.86.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, beating analysts’ consensus estimates of $0.50 by $0.02. The business had revenue of $936.00 million for the quarter, compared to analysts’ expectations of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The business’s quarterly revenue was down 4.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.49 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. As a group, analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, October 10th. Shareholders of record on Friday, September 26th were given a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, September 26th. This represents a $0.64 dividend on an annualized basis and a yield of 4.9%. DENTSPLY SIRONA’s dividend payout ratio is -13.50%.

Analyst Upgrades and Downgrades

Several research analysts have commented on XRAY shares. Stifel Nicolaus lowered their price objective on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a research report on Friday, August 8th. UBS Group lowered their price objective on shares of DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating for the company in a research report on Friday, August 8th. Needham & Company LLC reiterated a “hold” rating on shares of DENTSPLY SIRONA in a report on Friday, September 26th. Wells Fargo & Company reduced their price objective on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating on the stock in a research note on Friday, August 8th. Finally, Barrington Research reduced their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating on the stock in a research note on Friday, August 8th. Two investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of “Hold” and an average target price of $18.00.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.